4.59
Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten
Is Artelo Biosciences Inc. stock a top momentum playWeekly Earnings Recap & Weekly Breakout Opportunity Watchlist - newser.com
Artelo Biosciences Announces Pricing of $2.0 Million Public Offering - GlobeNewswire
Artelo Biosciences prices $2 million public offering of common stock By Investing.com - Investing.com Australia
$2 Million Capital Raise: Artelo Biosciences Prices Public Offering for Cancer Drug Development - Stock Titan
Form 424B5 ARTELO BIOSCIENCES, INC. - StreetInsider
Candlestick signals on Artelo Biosciences Inc. stock todayWeekly Profit Summary & Daily Volume Surge Trade Alerts - newser.com
Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Is Artelo Biosciences Inc. stock a defensive play in 20252025 Momentum Check & Consistent Profit Trading Strategies - newser.com
How Artelo Biosciences Inc. stock performs during Fed tightening cyclesQuarterly Trade Report & Community Verified Swing Trade Signals - newser.com
When is the best time to exit Artelo Biosciences Inc.Day Trade & Community Consensus Trade Alerts - newser.com
Artelo Biosciences launches underwritten public offering of stock - Investing.com India
Artelo Biosciences, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Artelo Biosciences Announces Proposed Underwritten Public Offering - GlobeNewswire
Nasdaq-Listed Biotech Artelo Biosciences Announces New Public Stock Offering for Cancer Research - Stock Titan
Can Artelo Biosciences Inc. stock surprise with earnings upsideWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Statistical indicators supporting Artelo Biosciences Inc.’s strengthJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com
How to track smart money flows in Artelo Biosciences Inc.Weekly Profit Report & Fast Exit and Entry Strategy Plans - newser.com
Artelo Biosciences (ARTL) Shares Promising Interim Data from Pha - GuruFocus
Artelo Biosciences Announces Presentation of Positive - GlobeNewswire
Artelo Biosciences Announces Presentation of Positive Interim Phase 2 CAReS Data on ART27.13 at the 2025 Cancer Cachexia Society Conference - MarketScreener
6% Weight Gain: Artelo's Cancer Cachexia Drug Shows Promising Results in Phase 2 Trial with Activity Boost - Stock Titan
Visual trend scoring systems applied to Artelo Biosciences Inc.Gold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Is Artelo Biosciences Inc. stock a safe haven assetEarnings Risk Summary & Growth Focused Stock Reports - newser.com
How to integrate Artelo Biosciences Inc. into portfolio analysis toolsTrade Performance Summary & Low Drawdown Investment Ideas - newser.com
Aug PreEarnings: What is Artelo Biosciences Incs TAM Total Addressable MarketQuarterly Profit Review & Verified Short-Term Plans - خودرو بانک
Can Artelo Biosciences Inc. continue delivering strong returnsPortfolio Risk Report & Verified High Yield Trade Plans - خودرو بانک
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):